Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vancomycin in Adults With Primary Sclerosing Cholangitis
NCT03710122Phase 3Terminated
- Start
- Jan 2020
- Primary completion
- Mar 2025
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin in Primary Sclerosing Cholangitis (PSC). Started Jan 2020; status: terminated.
02
Drugs
vancomycin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT03710122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710122.